Skip to main content
. 2026 Jul 20;17:1855538. doi: 10.3389/fimmu.2026.1855538

Figure 1.

Dot plot graphic displaying serum ADA levels in grams per milliliter by clinical response to adalimumab: complete, partial, or no response. Medians and interquartile ranges are shown. Complete responders have higher median ADA levels. Asterisks indicate statistically significant differences between groups.

Serum trough adalimumab levels according to clinical response in non-infectious uveitis. Serum trough levels of adalimumab (ADA) in patients with non-infectious uveitis stratified according to clinical response (complete response, partial response, and no response). Each dot represents an individual measurement (n = 135). Horizontal lines indicate median values with interquartile range (IQR). Patients with complete response had higher ADA levels compared with partial responders and non-responders at the time of measurement. Statistical comparisons were performed using the Kruskal–Wallis test followed by post hoc pairwise comparisons. *p < 0.05.